Latest Tumor suppressor genes Stories
It is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumors are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2.
Fulgent Therapeutics, a CLIA Certified Laboratory, announces today the inclusion of BRCA1 and BRCA2 analysis into its Hereditary Cancer Panel. Temple City, CA
Plaintiffs, including the American Civil Liberties Union, Association for Molecular Pathology, and American Society for Clinical Pathology, win long-fought case against Myriad Genetics, Association
A Salt Lake City, Utah-based genetics firm has lost a battle in court to keep a patent on naturally-occurring human genes.
Recently, Angelina Jolie made headlines with news that she had a double mastectomy as a result of testing positive for the BRCA gene mutation, a gene that has been linked to breast and ovarian
Researchers from the Masonic Cancer Center, University of Minnesota, and the University’s Brain Tumor Program, have developed a new mouse model of malignant peripheral nerve sheath tumors (MPNST) that allow them to discover new genes and gene pathways driving this type of cancer.
- The act of sweetening by admixture of some saccharine substance.